SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-006117
Filing Date
2020-05-11
Accepted
2020-05-11 08:01:13
Documents
60
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zyne-20200331x10q.htm 10-Q 1030736
2 EX-31.1 zyne-20200331ex311723409.htm EX-31.1 13576
3 EX-31.2 zyne-20200331ex3126d5d5d.htm EX-31.2 13370
4 EX-32.1 zyne-20200331ex32134e759.htm EX-32.1 6153
5 EX-32.2 zyne-20200331ex322e737c2.htm EX-32.2 6169
6 GRAPHIC zyne20200331x10q001.jpg GRAPHIC 78183
  Complete submission text file 0001558370-20-006117.txt   4690828

Data Files

Seq Description Document Type Size
7 EX-101.INS zyne-20200331.xml EX-101.INS 1016756
8 EX-101.SCH zyne-20200331.xsd EX-101.SCH 34674
9 EX-101.CAL zyne-20200331_cal.xml EX-101.CAL 37882
10 EX-101.DEF zyne-20200331_def.xml EX-101.DEF 137270
11 EX-101.LAB zyne-20200331_lab.xml EX-101.LAB 295992
12 EX-101.PRE zyne-20200331_pre.xml EX-101.PRE 258751
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37526 | Film No.: 20862672
SIC: 2834 Pharmaceutical Preparations